Measured Wealth Private Client Group’s Boston Scientific BSX Stock Holding History

Measured Wealth Private Client Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.5K	Sell	387 -158	-29%	-$8.58K	﹤0.01%	526
2026 Q1	$34.2K	Buy	545 +387	+245%	+$31K	0.01%	351
2025 Q4	$15.1K	Hold	158	–	–	﹤0.01%	524
2025 Q3	$15.4K	Buy	+158	New	+$16.4K	﹤0.01%	512
2018 Q4	–	Sell	-2,280	Closed	-$88K	–	182
2018 Q3	$88K	Buy	+2,280	New	+$79.6K	0.05%	254

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Measured Wealth Private Client Group's BSX Position: Q2 2026 in Review

Measured Wealth Private Client Group reduced its Boston Scientific (BSX) stake by 29% in Q2 2026, selling an estimated $8.58K and leaving 387 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Measured Wealth Private Client Group first reported a position in BSX in Q3 2018 and has held it in 5 quarters since. The position peaked at $88K in Q3 2018. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Measured Wealth Private Client Group held 387 shares of Boston Scientific worth $16.5K as of Q2 2026.
Measured Wealth Private Client Group sold 158 Boston Scientific shares in Q2 2026, an estimated $8.58K.
Boston Scientific made up ﹤0.01% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #526 holding.
Measured Wealth Private Client Group first reported a position in Boston Scientific in Q3 2018 and has held it in 5 quarters since.
Measured Wealth Private Client Group's Boston Scientific position peaked at $88K in Q3 2018.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.